• News
  • Movies
  • Money
  • Health
  • Videos
More
Hero Hero
  • Health News
  • Features
  • Food
  • Wellness
  • Diseases
  • Pregnancy
  • Parenting
  • Mental Health
  • Stress

WHO discontinues hydroxychloroquine, lopinavir/ritonavir trial for COVID treatment

Jul 5, 2020, 07:17 AM IST
T- T T+
covid
X
×

Geneva: The World Health Organization (WHO) announced on Saturday that it was discontinuing hydroxychloroquine and lopinavir/ritonavir arms for its Solidarity Trial, citing little or no reduction in the mortality of hospitalised Covid-19 patients.

The WHO said the decision was in light of the evidence from the Solidarity Trial interim results.

"These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized Covid-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect," the WHO said in a press release, Xinhua reported.

But the organization said this decision applies only to hospitalized patients and does not affect the possible evaluation in other studies of hydroxychloroquine or lopinavir/ritonavir in non-hospitalised patients or as pre- or post-exposure prophylaxis for Covid-19.

The Solidarity Trial was established by the WHO in March to find an effective Covid-19 treatment for hospitalised patients. It was originally designed to have five trial arms, including standard or usual care provided to Covid-19 patients, remdesivir, lopinavir/ritonavir combined, lopinavir/ritonavir combined with interferon beta, and hydroxychloroquine or chloroquine.

By enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival.

(IANS)

PRINT
EMAIL
COMMENT
 

Related Articles

Kerala reports 6,036 fresh Covid cases; test positivity rate jumps to 12.48 percent
News |
News |
One million COVID-19 vaccine doses administered in just 6 days; India surpasses UK, US
News |
India records 14,849 new corona cases; active cases 1.84 lakh
News |
Kerala reports most number of COVID-19 cases per day in India
 
 
  • Tags :
    • Corona Virus
    • COVID-19
More from this section
covid
Kerala reports most number of COVID-19 cases per day in India
Covaxin
Covaxin efficacy meets WHO standards, safe to use: Joint Drugs Controller
vaccine
COVID-19 vaccine race: Main candidates and where they stand
Telemedicine Services
Huge demand for telemedicine service in Kerala; 70,000 patients utilise facility
covid
Most hospitalised COVID-19 patients have at least one symptom 6 months after falling ill: Study
News in Videos
News+ Kerala India NRI World Columns Features Offbeat Good News Crime
Leisure Movies & Music Sports Travel Books
Learn Money Education Agriculture
Lifestyle Health Tech Food Astrology
Multimedia Gallery Videos Mojo News News In Pics
Our Network Malayalam Print Mathrubhumi News TV Kappa TV Club FM Seed Silver Bullet FindHome Media School MBIFL Redmic
E-Paper
Subscription
Buy Books
Magazines
Classifieds
Archives
 
  • E-Paper
  • Subscription
  • Buy Books
  • Magazines
  • Classifieds
  • Archives
© Copyright Mathrubhumi 2021. All rights reserved.
About Us Contact Us Privacy Policy
Terms of Use Archives
Ad Tariff Download App Classifieds
Buy Books Subscription e-Subscription
 
         
© Copyright Mathrubhumi 2021. All rights reserved.